RDY R&D to Revenue
Dr. Reddy's Laboratories Ltd Common Stock · R&D to Revenue
RDY R&D to Revenue
Latest reported7.14%period ending
RDY Quarterly R&D/Revenue (2.07% → 7.14%)
Latest values, visible window
High-resolution chart · PNG
RDY r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 7.1445% | |
| 7.2683% | |
| 7.0461% | |
| 7.0436% | |
| 7.307% | |
| 8.5328% | |
| 7.9654% | |
| 9.0704% | |
| 8.0715% | |
| 9.7092% | |
| 7.7133% | |
| 7.9169% | |
| 7.3964% | |
| 8.5218% | |
| 7.1211% | |
| 7.7216% | |
| 8.2927% | |
| 7.9569% | |
| 7.8181% | |
| 7.744% | |
| 9.2166% | |
| 8.6583% | |
| 8.3333% | |
| 8.9019% | |
| 9.0096% | |
| 9.4544% | |
| 9.0082% | |
| 7.6277% | |
| 9.3899% | |
| 9.1172% | |
| 9.5273% | |
| 10.8484% | |
| 11.1726% | |
| 12.3002% | |
| 12.2622% | |
| 11.7738% | |
| 15.305% | |
| 12.964% | |
| 13.4601% | |
| 14.6436% | |
| 14.9493% | |
| 13.287% | |
| 10.3203% | |
| 11.1585% | |
| 11.6744% | |
| 13.2932% | |
| 11.2305% | |
| 11.4635% | |
| 11.6744% | |
| 13.2932% | |
| 11.2305% | |
| 11.4635% | |
| 8.5416% | |
| 7.8269% | |
| 7.0678% | |
| 6.1057% | |
| 6.156% | |
| 6.5491% | |
| 5.4673% | |
| 6.4335% | |
| 6.0506% | |
| 7.3911% | |
| 6.8791% | |
| 6.79% | |
| 5.8998% | |
| 5.7967% | |
| 5.1573% | |
| 5.2428% | |
| 5.4154% | |
| 5.7126% | |
| 5.5812% | |
| 5.1062% | |
| 6.9823% | |
| 7.7238% | |
| 7.2552% | |
| 6.613% | |
| 6.7285% | |
| 5.4729% | |
| 4.3812% | |
| 2.0039% | |
| 3.7928% | |
| 9.7753% | |
| 8.7151% | |
| 7.6262% | |
| 9.212% | |
| 20.0469% | |
| 14.9943% | |
| 11.5888% | |
| 10.2859% | |
| 13.8208% | |
| 10.0513% | |
| 9.121% | |
| 6.7747% | |
| 11.4068% | |
| 7.2555% | |
| 7.5097% | |
| 4.5166% | |
| 7.2174% | |
| 5.1521% | |
| 3.1195% |